Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Gastrointestinal Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study will be a retrospective, registry study collecting data of patients who were diagnosed with benign or malignant gastrointestinal diseases. Data will be collected from patient's chart retrospectively once the patients have completed proper treatment follow up with physicians' practice.
Detailed description
It is reported in the literature that the treatment of any gastrointestinal disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with gastrointestinal cancer continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. The goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity.
The main aim of this study is to evaluate and compare the outcomes from our treatment of benign or malignant gastrointestinal diseases through medical chart review.
There is a need to understand and improve the current diagnosis and treatment algorithm for gastrointestinal pathologies. Continued evaluation and study is imperative to ensure that national guidelines are improving to enhance patient cure and/or recovery.
Primary outcome measures
- Overall survival [Time frame: Jan 2005 - Jan 2030]
- Overall symptom [Time frame: Jan 2005 - Jan 2030]
- Mortality [Time frame: Jan 2005 - Jan 2030]
- Morbidity [Time frame: Jan 2005 - Jan 2030]
Eligibility criteria
Inclusion criteria
- All patients diagnosed and treated for gastrointestinal diseases, benign or malignant from 2005 to 2030.
- Age ≥18 years
Exclusion criteria
- Patients that are not diagnosed with or treated for gastrointestinal diseases
- Age <18 years
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
United States · 1 center
- Methodist Richardson Medical Center — Richardson
Identifiers
NCT: NCT05115877 · 031.HPB.2020.R